Patents by Inventor Eric Novik

Eric Novik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200141926
    Abstract: An in vitro methods of characterizing biliary excretion of a chemical entity using a single hepatocyte culture. Comprising providing cell culture comprising hepatocytes forming at least one bile canaliculus; contacting the cell culture with a first chemical entity for a time sufficient to allow uptake of the chemical entity by hepatocytes in the culture; disrupting the at least one bile canaliculus without lysing the hepatocytes and detecting the amount (if any) of the first chemical entity and/or a metabolite thereof released by the at least one bile canaliculus; and lysing the hepatocytes and detecting the amount of the first chemical entity and/or a metabolite thereof released by the hepatocytes.
    Type: Application
    Filed: December 22, 2019
    Publication date: May 7, 2020
    Inventors: Eric NOVIK, Cheul CHO, Amit PAREKH, Robert FREEDMAN, Martin L. YARMUSH, Eric PLUDWINSKI
  • Publication number: 20180113119
    Abstract: Methods of characterizing the time-based hepatotoxicity of a test compound are provided. In some embodiments the provided methods allow prediction of the hepatotoxic potential of a test compound in a way that is improved relative to that achievable with prior art methods. In some embodiments the methods may be used to quantify the relationship between measurements or estimates of toxicity made at different, successive points in time, to provide highly meaningful tool to assess the likely in vivo hepatotoxicity of test compounds in vivo.
    Type: Application
    Filed: March 21, 2016
    Publication date: April 26, 2018
    Applicant: HUREL CORPORATION
    Inventors: Robert FREEDMAN, James MACDONALD, Eric NOVIK
  • Patent number: 9743875
    Abstract: The present invention is directed to an automated vessel puncture device, methods of mapping three-dimensional views of subcutaneous vessels and methods for providing simultaneous real-time diagnostic assay.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: August 29, 2017
    Assignee: VascuLogic, LLC
    Inventors: Tim Maguire, Kevin Nikitczuk, Martin Yarmush, Eric Novik, Stanley Dunn
  • Publication number: 20160137984
    Abstract: Compositions and methods described herein provide a cell culture system in which cells are in high metabolic states from the onset of the culture. Combinations of various cell culture components disclosed and employed herein allow cells to be in high metabolic states useful for drug testing immediately after the start of cell culture.
    Type: Application
    Filed: January 20, 2016
    Publication date: May 19, 2016
    Applicants: HUREL CORPORATION, GENERAL HOSPITAL CORPORATION
    Inventors: Martin Yarmush, Robert Freedman, Yaakov Nahmias, Eric Novik
  • Publication number: 20160061820
    Abstract: An in vitro methods of characterizing biliary excretion of a chemical entity using a single hepatocyte culture. Comprising providing cell culture comprising hepatocytes forming at least one bile canaliculus; contacting the cell culture with a first chemical entity for a time sufficient to allow uptake of the chemical entity by hepatocytes in the culture; disrupting the at least one bile canaliculus without lysing the hepatocytes and detecting the amount (if any) of the first chemical entity and/or a metabolite thereof released by the at least one bile canaliculus; and lysing the hepatocytes and detecting the amount of the first chemical entity and/or a metabolite thereof released by the hepatocytes.
    Type: Application
    Filed: September 2, 2015
    Publication date: March 3, 2016
    Inventors: Eric NOVIK, Cheul CHO, Amit PAREKH, Robert FREEDMAN, Martin L. YARMUSH
  • Patent number: 9243221
    Abstract: Compositions and methods described herein provide a cell culture system in which cells are in high metabolic states from the onset of the culture. Combinations of various cell culture components disclosed and employed herein allow cells to be in high metabolic states useful for drug testing immediately after the start of cell culture.
    Type: Grant
    Filed: November 24, 2009
    Date of Patent: January 26, 2016
    Assignees: HUREL CORPORATION, THE GENERAL HOSPITAL CORPORATION
    Inventors: Martin Yarmush, Robert Freedman, Yaakov Nahmias, Eric Novik
  • Publication number: 20150374273
    Abstract: The present invention is directed to an automated vessel puncture device, methods of mapping three-dimensional views of subcutaneous vessels and methods for providing simultaneous real-time diagnostic assay.
    Type: Application
    Filed: September 11, 2015
    Publication date: December 31, 2015
    Inventors: Tim MAGUIRE, Kevin NIKITCZUK, Martin YARMUSH, Eric NOVIK, Stanley DUNN
  • Publication number: 20110301500
    Abstract: The present invention is directed to an automated vessel puncture device, methods of mapping three-dimensional views of subcutaneous vessels and methods for providing simultaneous real-time diagnostic assay.
    Type: Application
    Filed: October 29, 2009
    Publication date: December 8, 2011
    Inventors: Tim Maguire, Kevin Nikitczuk, Martin Yarmush, Eric Novik, Stanley Dunn
  • Publication number: 20110014260
    Abstract: The present invention relates to systems and methods for maturation, proliferation and maintenance of function in cells presenting hepatocyte characteristics and differentiated from stem cells. The cells of the present invention may be generated from stem cell grown in collagen sandwich configuration in the presence of a morphogen (e.g. S-NitrosoAcetylPenicillamine (SNAP) or Oncostatin-M (OSM)).
    Type: Application
    Filed: September 11, 2008
    Publication date: January 20, 2011
    Inventors: Eric Novik, Martin L. Yarmush, Rene Schloss, Nripen Sharma